Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia

Hyper-inflammatory responses induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a major cause of disease severity and death. Predictive prognosis biomarkers to guide therapeutics are critically lacking. Several studies have indicated a “cytokine storm” with the release of in...

Full description

Bibliographic Details
Main Authors: André Santa Cruz, Ana Mendes-Frias, Ana Isabel Oliveira, Luís Dias, Ana Rita Matos, Alexandre Carvalho, Carlos Capela, Jorge Pedrosa, António Gil Castro, Ricardo Silvestre
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
COVID-19
IL-6
SARS-CoV-2
fatal pneumonia
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.613422/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.613422/full

Similar Items